TerrAscend's Q1 FY2026 shows modest revenue growth and a narrower net loss, but operating income slipped slightly. The balance sheet carries significant debt relative to cash, and recent convertible debenture issuance signals ongoing capital needs.
•Revenue rose 1.9% YoY to $65.5M, a deceleration from prior quarters, indicating sluggish top-line growth.
•Net loss improved 34.8% YoY to -$8.0M (EPS -$0.03 vs -$0.05), but operating income dipped 5.9% to $11.5M, suggesting cost pressures.
•Cash of $39.0M is low against long-term debt of $219.9M (debt-to-cash ratio ~5.6x), highlighting balance-sheet strain.
•Two dilution events in the past 12 months and a June 2026 convertible debenture filing point to continued reliance on equity-linked financing.
Informational summary based on SEC XBRL figures · generated by AI agent. Not investment advice.
A Canada-headquartered cannabis company with its primary growth engine in the US, holding leading market positions in New Jersey, Pennsylvania, Maryland, and Michigan.
🇨🇦 Canadian holding structure bridges both markets while keeping US operations at the forefront
🏆 The State House dispensary brand in Pennsylvania has consistently ranked among the top performers by sales
🧪 Ilera Healthcare subsidiary operates one of Pennsylvania's largest cultivation and processing facilities
TerrAscend is a Canada-headquartered cannabis company that operates as a multi-state operator (MSO) in the United States. Its primary growth engine is in the US, where it holds leading market positions in New Jersey, Pennsylvania, Maryland, and Michigan. The company focuses on cultivation, processing, and retail operations. Through its Ilera Healthcare subsidiary, TerrAscend operates one of Pennsylvania's largest cultivation and processing facilities. Its retail presence includes The State House dispensary brand, which has consistently ranked among the top performers by sales in Pennsylvania.
What is TerrAscend's business model?
TerrAscend's business model is that of a vertically integrated multi-state cannabis operator (MSO). It engages in cultivation, processing, and retail sales across several US states. The company grows and processes cannabis flower and manufactured products, which are then sold through its own dispensaries and wholesale to other retailers. Its Ilera Healthcare subsidiary operates a large cultivation and processing facility in Pennsylvania, supplying both its own The State House dispensaries and third-party retailers. This vertical integration allows TerrAscend to capture margins at multiple stages of the supply chain.
In which US states does TerrAscend operate?
TerrAscend holds leading market positions in four US states: New Jersey, Pennsylvania, Maryland, and Michigan. These states represent the company's primary growth engine. In Pennsylvania, TerrAscend operates The State House dispensary brand, which is among the top-performing dispensaries by sales in the state. The company also has a significant cultivation and processing footprint in Pennsylvania through its Ilera Healthcare subsidiary. While headquartered in Canada, TerrAscend's operations are heavily focused on the US market, leveraging its Canadian holding structure to bridge both markets.
What category of cannabis company is TerrAscend?
TerrAscend is classified as a US multi-state cannabis operator (MSO). This category includes companies that operate in multiple US states where cannabis is legal, typically with vertically integrated operations spanning cultivation, processing, and retail. As an MSO, TerrAscend competes with other large operators like Curaleaf, Trulieve, and Green Thumb Industries. Its Canadian holding structure allows it to access capital markets while maintaining US operations. The company's focus on leading medical and adult-use markets in the Northeast and Midwest positions it as a key player in the US cannabis sector.
What are TerrAscend's notable brands or facilities?
TerrAscend's notable retail brand is The State House, a dispensary chain in Pennsylvania that has consistently ranked among the top performers by sales in the state. On the production side, its subsidiary Ilera Healthcare operates one of Pennsylvania's largest cultivation and processing facilities. This facility supplies both The State House dispensaries and wholesale customers. Additionally, TerrAscend holds leading market positions in New Jersey, Maryland, and Michigan, though specific brand names in those states are not detailed in the available data. The company's Canadian headquarters provide a unique corporate structure that bridges US and Canadian cannabis markets.
